BUYER READINESS
MEDDIC is the most rigorous qualification framework in B2B sales. If you're running it well, you know more about your pipeline than ninety percent of your competitors. You disqualify bad deals faster. You build forecasts on evidence instead of hope. That discipline is real and worth keeping.
And it's not preventing the problem you're seeing: qualified deals dying in committee, three weeks of silence after a clean demo, forecasts that slip on the deals you were most sure of.
A deal checks every box. Metrics confirmed. Economic Buyer identified. Champion engaged. Pain quantified. Decision Process mapped. Three weeks after the demo, silence. Not because MEDDIC failed. Because MEDDIC was never designed to measure whether the buyer has completed the internal work required to say yes.
Most B2B revenue problems get solved at the seller level. DecisionScope exists because the real bottleneck is on the buyer side, and MEDDIC was never built to reach it. The pillar lives at /buyer-readiness. Sibling head-to-heads: vs BANT, vs Challenger, vs SPIN.
What MEDDIC Measures (And Why It Earned Its Place)
MEDDIC was created by Jack Napoli at PTC in the late 1990s for enterprise B2B software sales with long, multi-stakeholder cycles. The framework tracks six elements of deal qualification. MEDDPICC adds two more. Together, they answer one question: does this deal have the conditions to close?
The six elements: Metrics (quantifiable economic impact), Economic Buyer (the person with discretionary budget authority), Decision Criteria (the technical and business criteria), Decision Process (the buyer's internal procurement and approval steps), Identify Pain (the specific business pain driving the purchase), Champion (the internal advocate). MEDDPICC adds Paper Process and Competition.
MEDDIC assumes the buyer's decision process is observable and stable from the seller's side. If you've identified the right people, the right pains, the right criteria, the qualification holds. That assumption holds when the buyer-side decision is a black box the seller does not need to look inside. It breaks when the buyer's internal decision is incomplete, which is most of the time. The framework maps the deal's conditions from the outside. It does not tell your rep what the buyer hasn't resolved on the inside.
The Gap Between Qualification and Decision
If you've run MEDDIC well and deals still stall, the instinct is to assume your team isn't running it well enough. That's usually not the problem. MEDDIC confirms four things the seller can observe. None of them measure whether the buyer can complete the decision the qualification assumes is coming.
What MEDDIC confirms vs. what it cannot see
- MEDDIC confirms an Economic Buyer exists. It does not check whether that buyer has resolved their own hesitation about acting. A VP can have full budget authority and still not be ready to spend it, because they haven't internalized the cost of doing nothing.
- MEDDIC confirms Pain has been identified. It does not check whether the buyer has internalized that pain deeply enough to prioritize this decision over the fourteen other priorities competing for their attention this quarter. Kahneman and Tversky established that buyers feel losses approximately 2.25 times more intensely than equivalent gains, but loss aversion only activates when the buyer has internalized the loss themselves. Without that conviction, pain sits in your CRM as a confirmed data point and in the buyer's mind as an acknowledged fact they haven't acted on.
- MEDDIC confirms a Champion is in place. It does not check whether that champion can mobilize supporters, buffer opposition, and moderate conflict — the three tactics peer-reviewed research identifies as the actual mechanism of internal selling (de Roo et al., Strategic Organization, 2024). MEDDIC's Champion field has no slot for any of those three.
- MEDDIC confirms a Decision Process. It does not check whether the buying group has the alignment to execute that process. B2B win rates peak at four to five stakeholders and decline beyond six (Brontén & Cabrera, J Systems Thinking, 2025). MEDDIC was built for a peak-three era. The decision process map does not capture whether the seventh, eighth, or thirteenth stakeholder can be brought into alignment.
What the data shows
- Forty to sixty percent of qualified B2B deals end in no decision, not lost to a competitor. Abandoned by a buyer who couldn't complete the decision.
- Fifty-six percent of those losses come from buyer indecision, not a deliberate preference for the status quo.
- When sellers respond by pushing harder, win rates degrade by eighty-four percent.
- The average B2B buying group is thirteen internal stakeholders plus nine external influencers, and seventy-four percent of buyer teams demonstrate unhealthy conflict during decision processes.
None of those numbers describe a qualification problem. They describe a buyer-readiness problem. MEDDIC qualified the deal. The deal still died.
The deeper finding from organizational research: coalitions form through identifiable processes — shared interest identification, communication, mutual commitment (Stevenson, Pearce & Porter, Academy of Management Review, 1985). MEDDIC's Champion field captures none of those processes. A confirmed Champion is an input. A formed coalition is the output. The gap between the two is where 56% of your qualified pipeline goes to die.
These aren't unqualified deals. They passed the MEDDIC check. They had metrics, an economic buyer, a champion, confirmed pain. They died because qualification measures whether the conditions are right. It doesn't measure whether the buyer is ready.
The Dimensions MEDDIC Wasn't Built to Measure
MEDDIC's blind spot is most acute in two of the four buyer readiness dimensions. The other two it touches but does not measure with discipline.
The four dimensions through the MEDDIC lens
- Problem Conviction. MEDDIC confirms Pain exists. It does not measure the distance between “we know this is a problem” and “we are going to do something about this problem right now.” That distance is where urgency lives or dies.
- Evaluation Clarity. MEDDIC confirms Decision Criteria are documented. It does not measure whether the buyer has a decision framework they trust independent of the seller's pitch. A criteria list filled in by the rep is not the same as a buyer-internalized framework that survives committee review.
- Outcome Confidence. MEDDIC confirms Metrics. It does not measure whether the buyer believes those metrics will materialize in their specific environment, with their data, their team, their constraints.
- Organizational Readiness. The deepest blind spot. MEDDIC identifies a Champion and maps a Decision Process. It does not measure whether the buying group can align. Ninety-one percent of B2B purchases stall somewhere in the buying process, and most of those stalls happen in the space between a confirmed champion and an aligned buying group.
The four dimensions form a chain. The deal moves at the speed of the weakest link. Three dimensions at full strength plus one incomplete equals a dead deal.
Each dimension has a resolution protocol. The Urgency, Framework, Proof, and Alignment Protocols close the four gaps respectively. MEDDIC has no equivalent to any of them. That is not a flaw. It is the edge of what a qualification framework was ever designed to do.
How Qualification and Diagnosis Work Together
MEDDIC says: “This deal is qualified.” DecisionScope says: “This buyer is ready to decide.” Both statements can be true. Both can be false. The dangerous combination is the first being true while the second is false. That's the deal your forecast counts on that quietly disappears.
The integration runs in four steps. Qualify with MEDDIC at the start of every opportunity. Run the DecisionScope diagnostic in parallel to score the four readiness dimensions. At the decision checkpoint (the moment the rep would normally push), check the readiness read. If a dimension is incomplete, run the matching protocol before the deal goes quiet.
Here's what that looks like in practice. A deal in Stage 3 just passed MEDDIC cleanly. Champion identified. Pain confirmed. Demo booked for next week. Everything checks out.
The contrast
- Without a diagnostic. The rep runs the demo. The champion is enthusiastic. Three weeks later, silence. The deal slips to next quarter, then the quarter after that, then closes lost-no-decision.
- With a DecisionScope diagnostic at Stage 3. Problem Conviction confirmed. Evaluation Clarity confirmed. Outcome Confidence confirmed. Organizational Readiness at 2 out of 5. The champion has no stakeholder map, has not identified the CFO as a silent blocker, and has no internal selling materials. Three dimensions passed. The fourth kills the deal.
With the MEDDIC qualification alone, the team pushes forward. With the DecisionScope diagnostic, the team runs the Alignment Protocol: map the buying group, identify the conflict sources, equip the champion with stakeholder-specific materials before the demo happens. Different move. Different outcome.
The research validates the layered approach. Dixon and McKenna found a 14% close rate when sellers only diagnosed the problem without prescribing a resolution. When diagnosis was paired with a specific protocol recommendation, close rates jumped to 36%. Knowing the gap exists isn't enough. Knowing which protocol resolves it is what moves the number.
When to Use Which
Use MEDDIC to decide which deals deserve your team's resources. Qualification prevents your reps from spending forty-five-minute demos on prospects who don't have budget authority or a defined decision process. That discipline is indispensable.
When to escalate from MEDDIC alone to MEDDIC plus diagnostic
- The deal involves a buying committee larger than five stakeholders. Above the peak-five threshold, win rates decline by stakeholder count alone. MEDDIC's Champion field cannot reach that population.
- The cycle is going to run past a single quarter. Time creates the space for buyer-side avoidance and committee drift. MEDDIC's qualification holds; the readiness changes underneath it.
- Your no-decision losses exceed a quarter of total losses. Above that threshold, MEDDIC alone is a forecast with a blind spot.
- The qualified deal goes quiet after a clean demo. The answer is not “push harder.” The answer is diagnosing which readiness dimension is incomplete and applying the right resolution before silence becomes permanent.
Use both for the highest-fidelity pipeline intelligence available. Qualify first, then diagnose readiness before the demo. The result: fewer surprises in your forecast, fewer qualified deals dying in committee, and specific action plans for every stalled deal instead of generic follow-up sequences.
Whatever qualification framework your team runs, DecisionScope adds the readiness layer beneath it.
Take the free Buyer Readiness Check → Score your pipeline across four dimensions in under four minutes.
Frequently Asked Questions
Does DecisionScope replace MEDDIC?
No. DecisionScope is a diagnostic layer beneath MEDDIC, not a replacement. MEDDIC qualifies the deal's conditions: metrics, economic buyer, decision criteria, champion, pain. DecisionScope measures whether the buyer has completed the internal decisions that make those conditions actionable. A deal can pass every MEDDIC criterion and still die because the buyer never resolved their outcome uncertainty or organizational alignment. The two instruments measure different things. Use both.
Can I use DecisionScope with MEDDPICC?
Yes. MEDDPICC adds Paper Process and Competition to the standard MEDDIC framework, which strengthens qualification. DecisionScope adds the readiness layer that neither MEDDIC nor MEDDPICC covers: whether the buyer has reached problem conviction, evaluation clarity, outcome confidence, and organizational readiness. The additional MEDDPICC fields are complementary to the DecisionScope dimensions, not overlapping.
What's the difference between deal qualification and buyer readiness?
Deal qualification asks: does this opportunity have the right conditions to close? Budget exists, decision-maker identified, pain confirmed, timeline established. Buyer readiness asks: has the buyer completed the internal work required to say yes? Problem conviction internalized, evaluation framework in place, outcome confidence established, buying group aligned. A deal can be fully qualified and completely unready. That gap is where 40-60% of qualified pipeline goes to die.
How long does a DecisionScope assessment take?
The free Buyer Readiness Check takes under four minutes and provides preliminary readiness scores across all four dimensions. A full DecisionScope diagnostic covers individual deal scoring with evidence documentation and protocol recommendations. Timeline varies based on pipeline scope and complexity.
FAQ
Does DecisionScope replace MEDDIC?
No. DecisionScope is a diagnostic layer beneath MEDDIC, not a replacement. MEDDIC qualifies the deal's conditions: metrics, economic buyer, decision criteria, champion, pain. DecisionScope measures whether the buyer has completed the internal decisions that make those conditions actionable. A deal can pass every MEDDIC criterion and still die because the buyer never resolved their outcome uncertainty or their buying group never aligned. The two instruments measure different things. Use both.
Can I use DecisionScope with MEDDPICC?
Yes. MEDDPICC adds Paper Process and Competition to the standard MEDDIC framework, which strengthens qualification. DecisionScope adds the readiness layer that neither MEDDIC nor MEDDPICC covers: whether the buyer has reached problem conviction, evaluation clarity, outcome confidence, and organizational readiness. The additional MEDDPICC fields are complementary to the DecisionScope dimensions, not overlapping.
Why do MEDDIC-qualified deals still end in no decision?
Because MEDDIC measures conditions a seller can observe, and completion depends on readiness states the seller usually cannot. A deal can clear Metrics, Economic Buyer, Decision Criteria, Decision Process, Pain, and Champion and still stall because the buyer lacks conviction the problem outweighs the risk, has no decision framework they trust, cannot picture the outcome working in their environment, or sits inside a buying group that cannot align. MEDDIC's Champion field captures none of the three internal-selling tactics (mobilize, buffer, moderate) that peer-reviewed research identifies as the actual mechanism of coalition formation.
How long does a DecisionScope assessment take?
The free Buyer Readiness Check takes about four minutes and gives a first read on which of the four dimensions is the weakest link in a specific deal. The full diagnostic, applied across a live pipeline with evidence gathered per dimension, runs up to about five days. Either way, it runs after MEDDIC, on deals that have already cleared qualification. It is not a second qualification gate. It is a forecast-quality check on the deals MEDDIC already qualified.
How is buyer readiness different from MEDDIC's Champion?
MEDDIC's Champion confirms an internal advocate exists. DecisionScope's Organizational Readiness measures whether that advocate can actually drive a coalition. Peer-reviewed research (de Roo et al., 2024) shows champions use three tactics — mobilizing supporters, buffering opposition, and moderating conflict. MEDDIC captures none of those. A confirmed Champion is the input. A formed coalition is the output. The gap is where most MEDDIC-qualified pipeline dies.
Will MEDDIC alone work for smaller deal sizes?
Often, yes. When the deal is transactional and a small buying group (three or fewer stakeholders) owns the decision, MEDDIC is measuring the actual decision-makers rather than proxies for a committee. Research shows B2B win rates peak at four to five stakeholders. Below that ceiling, MEDDIC qualification is usually sufficient. Above it, MEDDIC alone is solving for the wrong half of the problem. The diagnostic earns its place when the decision involves a coalition, which is where Organizational Readiness becomes the deciding factor.